Clinical trial
Identification of Predictors for the Evolution of COVID-19 Related Interstitial Pneumonia by Transcriptomic and Seroproteomic Techniques
NCT04441502 is registered in ClinicalTrials.gov with IRCCS Policlinico S. Donato as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identification of Predictors for the Evolution of COVID-19 Related Interstitial Pneumonia by Transcriptomic and Seroproteomic Techniques
- Lead sponsor
- IRCCS Policlinico S. Donato
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 30, 2020
- Completion date
- December 31, 2024
- Enrollment
- 204 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid19, interstitial pneumonia